|
Market Closed -
Nasdaq
16:00:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 2.640 USD | +2.33% |
|
+2.72% | -15.92% |
| 08-20 | AC Immune Reports Positive Preliminary Phase 1 Results for ACI-19764 | MT |
| 08-11 | AC Immune Shares Rise on FDA's Fast-Track for Parkinson's Disease Drug | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ACIU Stock
- Consensus AC Immune SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
